Yinhong Bushen Yao Jiu (银红补肾药酒)银红补肾药酒
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 甘肃瑞霖医药科技有限责任公司Chinese legal name: 甘肃瑞霖医药科技有限责任公司
主要成分Active Ingredients
- 红花Hong Hua
- 黑芝麻Heizhi Ma
- 清酒Qing Jiu
药物知识说明
红花是一种在国家药监局注册认定的药品。该药品含有红花、黑芝麻-131783fd等成分。
该药品关联的活性成分包括：红花Hong Hua、黑芝麻Heizhi Ma。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：甘肃瑞霖医药科技有限责任公司Chinese legal name: 甘肃瑞霖医药科技有限责任公司。
您可以探索含有相同成分的其他药品：红花-6713ea56成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 银红补肾药酒) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 红花Hong Hua, 黑芝麻Heizhi Ma.
Manufacturers recorded for this product: 甘肃瑞霖医药科技有限责任公司Chinese legal name: 甘肃瑞霖医药科技有限责任公司.
Explore other medicines containing the same ingredient: 红花 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 银红补肾药酒Recorded Chinese name: 银红补肾药酒
- 规格Specification: 200ml/瓶200 mL/bottle
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 甘肃瑞霖医药科技有限责任公司Chinese legal name: 甘肃瑞霖医药科技有限责任公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字B20020246
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字B20020246
Manufacturer
Chinese legal name: 甘肃瑞霖医药科技有限责任公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字B20020246
生产企业
甘肃瑞霖医药科技有限责任公司(国产)
适应症
活血养血，补肾安神。用于失眠的辅助治疗，亦可改善神疲乏力，腰膝酸软，畏寒肢冷，夜尿频多。
用法用量
口服，一次20～30毫升，一日1次。晚服。
不良反应
个别患者服药后胃有灼热感、口干现象。
禁忌
儿童、孕妇、哺乳期妇女禁用；妇女月经量多或有出血倾向者禁用；对酒精过敏者禁用。
注意事项
1.忌烟、酒及辛辣、油腻食物。|2.阴虚火旺者症见头晕、心烦、手足心发热者慎用。|3.本品含乙醇量35～45%；不胜酒者慎服。|4.服药期间要保持情绪乐观，切忌生气恼怒。|5.有高血压、心脏病、糖尿病、肝病、肾病等慢性病严重者应在医师指导下服用。|6.服药7天症状无缓解，应去医院就诊。|7.年老体弱者应在医师指导下服用。|8.对本品过敏者禁用，过敏体质者慎用。|9.本品性状发生改变时禁止使用。|10.请将本品放在儿童不能接触的地方。|11.如正在使用其他药品，使用本品前请咨询医师或药师。
贮藏
密闭，置阴凉处。
规格
200ml/瓶
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.